文献速递重症综合管理与镇静镇痛

1998至2025年脓毒症与代谢重编程研究:文献计量学与可视化分析

Research on Sepsis and Metabolic Reprogramming from 1998 to 2025: A Bibliometric and Visualized Analysis.
PubMed 文献 · Shock · 2025-09-23
一句话结论文献计量分析显示脓毒症代谢重编程研究持续增长,美国发文24.3%、中国23.4%,免疫代谢、线粒体调控、肠道菌群失衡、表观遗传修饰及mTOR/AMPK/HIF-1α轴和Sirtuin家族通路为研究热点。

该研究基于Web of Science核心合集Science Citation Index Expanded数据库,检索并分析672篇英文原创研究论文和综述,使用R-bibliometrix、VOSviewer和CiteSpace对脓毒症代谢重编程研究进行文献计量学与可视化分析。结果显示该领域发文量和被引频次持续上升,美国(占总发文24.3%)和中国(23.4%)为最高产国家,美国保持最高被引频次优势;Wake Forest University发表54篇高影响力文章居机构首位;Frontiers in Immunology、Shock和Critical Care为主要学术平台。免疫代谢、线粒体调控、肠道菌群失衡、表观遗传修饰以及mTOR/AMPK/HIF-1α轴和Sirtuin家族通路被识别为关键研究热点,靶向代谢调节的新型治疗手段(药物、天然化合物、干细胞疗法、非编码RNA干预)快速涌现。结论认为脓毒症代谢重编程研究前景良好,关键机制研究和代谢靶向干预开发是未来脓毒症防治策略的重要优先方向。

要点

  • 美国发文量占总发文24.3%、中国占23.4%,美国被引频次最高,提示美国在该领域学术影响力领先。
  • Wake Forest University发表54篇高影响力文章,居机构首位;Frontiers in Immunology、Shock和Critical Care为该领域主要学术平台。
  • 免疫代谢、线粒体调控、肠道菌群失衡、表观遗传修饰为识别出的关键研究热点。
  • mTOR/AMPK/HIF-1α轴和Sirtuin家族通路为识别出的关键研究热点通路。
  • 靶向代谢调节的新型治疗手段快速涌现,包括药物、天然化合物、干细胞疗法和非编码RNA干预。

研究设计与关键结果

  • 研究为文献计量学与可视化分析,基于Web of Science核心合集Science Citation Index Expanded数据库检索并分析672篇英文原创研究论文和综述,使用R-bibliometrix、VOSviewer和CiteSpace进行多维分析(学术产出趋势、地理分布、机构与作者合作网络、突现检测、研究热点演变)。结果显示发文量和被引频次持续上升;美国占总发文24.3%、中国占23.4%,美国被引频次最高;Wake Forest University发表54篇高影响力文章居机构首位;Frontiers in Immunology、Shock和Critical Care为主要学术平台;免疫代谢、线粒体调控、肠道菌群失衡、表观遗传修饰以及mTOR/AMPK/HIF-1α轴和Sirtuin家族通路为关键研究热点;

证据类型、等级与局限

  • 证据类型:文献计量学与可视化分析(基于数据库检索的原创研究论文和综述的二次分析);局限:原文未报告局限性。

对床旁实践的改变

  • 原文结论认为脓毒症代谢重编程研究前景良好,关键机制研究和代谢靶向干预开发是未来脓毒症防治策略的重要优先方向;原文未据此给出具体临床推荐。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「适用人群与场景」「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Metabolic reprogramming has emerged as a central mechanism in sepsis pathogenesis, influencing immune responses, organ dysfunction, and therapeutic outcomes. This study conducts a comprehensive bibliometric analysis to map the research landscape, identify key trends, and highlight future directions in this field.

METHODS: Based on the Science Citation Index Expanded database in Web of Science Core Collection database, we retrieved and analyzed 672 English-language original research articles and reviews. Using R-bibliometrix, VOSviewer, and CiteSpace, we performed a multidimensional analysis of academic output trends, geographical distribution, institutional and author collaboration networks, burst detection, and the evolution of research hotspots.

RESULTS: The analysis reveals a consistent upward trend in both publication output and citation frequency within this research domain. The United States (24.3% of total publications) and China (23.4%) have emerged as the most productive contributing nations. Notably, the United States maintains superior academic influence as evidenced by its highest citation frequency. Among institutions, Wake Forest University in the United States holds a preeminent position, having published 54 high-impact articles in this field. The journals Frontiers in Immunology , Shock , and Critical Care represent the premier academic platforms in this research domain. Immunometabolism, mitochondrial regulation, gut microbiota imbalance, and epigenetic modifications, along with the mammalian target of rapamycin/AMP-activated protein kinase/hypoxia-inducible factor 1-alpha axis and the Sirtuin family pathway, have been identified as the key research hotspots. Novel therapeutic approaches targeting metabolic regulation are rapidly emerging, including pharmacological agents, natural compounds, stem cell-based therapies, and noncoding RNA interventions.

CONCLUSION: Research on metabolic reprogramming in sepsis shows promising prospects, with investigations into key mechanisms focusing on current research hotspots and the development of metabolism-targeted interventions emerging as critical priorities for future sepsis prevention and treatment strategies.

来源:Shock,查看原文。版权归原作者所有。

参考来源

  1. Fang Y, Dou A, Zhang Y, et al. Research on Sepsis and Metabolic Reprogramming from 1998 to 2025: A Bibliometric and Visualized Analysis. Shock. 2025. PMID: 40986928. doi:10.1097/SHK.0000000000002714

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。